Home > Neurotrophic Keratitis > Quiz: Topical Insulin for Persistent Corneal Epithelial Defects Neurotrophic Keratitis Quiz: Topical Insulin for Persistent Corneal Epithelial Defects Ophthalmology 360 <section data-block="SingleChoice"><h3>According to current evidence, where does topical insulin fit within the therapeutic pathway for PED?</h3><ul><li>As first-line therapy before conventional treatment</li><li>After conventional therapy and before autologous serum</li><li>Only after failure of surgical intervention</li><li>As a replacement for all other medical therapies</li></ul></section><section data-block="SingleChoice"><h3>What outcome has been observed in multiple studies evaluating topical insulin for PED?</h3><ul><li>They delay epithelial healing compared with conventional therapy</li><li>They provide similar results to autologous serum in all cases</li><li>They may promote faster and more consistent epithelial healing</li><li>They are only effective when combined with surgical therapy</li></ul></section><section data-block="SingleChoice"><h3>What is the typical next step for patients who do not respond to topical insulin therapy?</h3><ul><li>Escalate to surgical interventions such as amniotic membrane transplantation</li><li>Switch to higher-dose insulin eye drops</li><li>Continue insulin indefinitely</li><li>Stop all topical therapy</li></ul></section> Share Related Content Retina Care 360 Quiz: Mental health risks linked to age-related eye disease Dry Eye Quiz: Understanding meibomian gland dysfunction and its management Dry Eye Quiz: Emerging Therapies in DED Cornea and External Disease Quiz: Refractive Surgery in Patients With Diabetes Retinopathy of Prematurity Quiz: ROP Pharmacologic Strategies Polls & Quizzes Quiz: Teaching points from patient-reported dry eye behavior data Share
